Willy,
The action of yesterday was surprising ..... although I did mention previously that one of my all time favorite buy signals was setting up if the stock moved above .22.
Personally I don't believe you'll get either news items this week and your focus is a little too narrow.
PAZ and fractions thereof have been proven with statistical certainty to work in both hamsters (and PAZ itself in humans) for cholesterol regulation. That is indisputable. And .... at a genetic level instead of how statins works .... which can damage the liver.
What happens if it is found PF4 can be replicated on a mass scale, concentrated and/or delivered via alternate means ?? Basically you need to absorb what that means to determine what HEPI's future potential could be as a licensing company.
Speak to any scientist with regard to inflammation ..... you'll find it is considered the Holy Grail when one considers the large number of illnesses that originate with inflammation.
Xooma is a drop in the bucket compared to what may be possible.
Amigo Mike
News 
Market Data 
Discover 
AI
